Coexpression of CD43 by benign B cells in the terminal ileum

Po-Shing Lee1, Debra Beneck, James Weisberger

  • 1From Division of Hematopathology, IMPATH Inc, New York, NY 10019, USA.

Insights

CD43 expression on B cells can indicate lymphoproliferative disorders. However, benign B cells in the terminal ileum frequently express CD43, making it unreliable for diagnosing MALT lymphoma versus reactive conditions.

Area of Science:

  • Immunohistochemistry
  • B-cell lymphomas
  • Gastrointestinal pathology

Background:

  • CD43 expression on B cells is a diagnostic marker for B-cell lymphoproliferative disorders.
  • Benign B cells typically do not coexpress CD43.
  • Distinguishing extranodal marginal zone B-cell lymphoma of MALT type from reactive processes can be challenging.

Purpose of the Study:

  • To investigate CD43 expression in benign B cells within the terminal ileum.
  • To determine if CD43 coexpression in the terminal ileum is a reliable indicator of B-cell lymphoproliferative disorders.

Main Methods:

  • Analysis of 20 terminal ileum biopsies for nonneoplastic disease.
  • Assessment of CD43 expression alongside CD20, CD138, and CD3 reactivity.
  • Comparison of CD43 expression in the terminal ileum with other anatomical sites.

Main Results:

  • 85% of cases showed strong CD43 coexpression in benign perifollicular B cells.
  • Benign B cells in the terminal ileum, including Peyer's patches, frequently express CD43.
  • CD43 coexpression was observed in benign B-cell populations.

Conclusions:

  • CD43 coexpression in terminal ileum B cells, including Peyer's patches, is common in benign conditions.
  • CD43 should not be used as a sole diagnostic marker to differentiate MALT lymphoma from reactive processes in the terminal ileum.

Related Concept Videos

Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...